Related references
Note: Only part of the references are listed.Genetic Modifiers and Phenotype of Duchenne Muscular Dystrophy: A Systematic Review and Meta-Analysis
Carlos Pascual-Morena et al.
PHARMACEUTICALS (2021)
The Usual Suspects: Genes for Inflammation, Fibrosis, Regeneration, and Muscle Strength Modify Duchenne Muscular Dystrophy
Luca Bello et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Long-range genomic regulators of THBS1 and LTBP4 modify disease severity in duchenne muscular dystrophy
Robert B. Weiss et al.
ANNALS OF NEUROLOGY (2018)
DMD genotype correlations from the Duchenne Registry: Endogenous exon skipping is a factor in prolonged ambulation for individuals with a defined mutation subtype
Richard T. Wang et al.
HUMAN MUTATION (2018)
Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data
Marika Pane et al.
PLOS ONE (2018)
Progressive left ventricular dysfunction and long-term outcomes in patients with Duchenne muscular dystrophy receiving cardiopulmonary therapies
Mary Wang et al.
OPEN HEART (2018)
Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy
Luca Bello et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study
Luca Bello et al.
NEUROLOGY (2016)
Genetic Modifiers of Ambulation in the Cooperative International Neuromuscular Research Group Duchenne Natural History Study
Luca Bello et al.
ANNALS OF NEUROLOGY (2015)
Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants
Janneke C. van den Bergen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy
Andrea Barp et al.
PLOS ONE (2015)
6 Minute Walk Test in Duchenne MD Patients with Different Mutations: 12 Month Changes
Marika Pane et al.
PLOS ONE (2014)
LTBP4 genotype predicts age of ambulatory loss in duchenne muscular dystrophy
Kevin M. Flanigan et al.
ANNALS OF NEUROLOGY (2013)
Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy
Anna Mayhew et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2013)
The cooperative international neuromuscular research group duchenne natural history studya longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used
Craig M. McDonald et al.
MUSCLE & NERVE (2013)
Motor and respiratory heterogeneity in Duchenne patients: Implication for clinical trials
Veronique Humbertclaude et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2012)
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy
E. Pegoraro et al.
NEUROLOGY (2011)
Reliability of the North Star Ambulatory Assessment in a multicentric setting
E. S. Mazzone et al.
NEUROMUSCULAR DISORDERS (2009)
Intronic breakpoint definition and transcription analysis in DMD/BMD patients with deletion/duplication at the 5′ mutation hot spot of the dystrophin gene
F Gualandi et al.
GENE (2006)
Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy
G Felisari et al.
NEUROLOGY (2000)
Share Paper
